Machine Learning Tool Can Predict Risk of Fatty Liver Disease

A U.S. appeals court upheld a judge’s previous decision to throw out a record-setting 2016 verdict in Merck’s favor.

Adults with chronic liver disease are more than twice as likely than those without the condition to have barriers to medical care.

Nevertheless, researchers are hoping to learn more from the study of the caspase inhibitor among people with non-alcoholic steatohepatitis.

A new classification system may more accurately reflect liver-related death trends in the United States.

The difference between hepatitis C virus and its antibodies can be confusing to understand, but important to know.

Drugs that have a favorable effect on biomarkers may still play a role in combination therapy, however.

Some study participants experienced hepatitis B surface antigen loss, considered a functional cure.

This is the first major study to assess an eight-week regimen in people with all genotypes of hep C and compensated cirrhosis.

Ninety-seven percent of the children were cured of hepatitis C.